Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Cyclo Therapeutics Inc (CYTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2008	12-2007	12-2006	12-2005	12-2004
Cash Flows From Operating Activities
Net Income	-413	650	-100	-170	-560
Depreciation Amortization	23	20	20	30	20
Income taxes - deferred	200	N/A	N/A	N/A	N/A
Accounts receivable	58	N/A	N/A	N/A	N/A
Other Working Capital	-46	-10	-40	20	80
Other Operating Activity	243	-290	140	240	660
Operating Cash Flow	$65	$370	$20	$120	$200

Cash Flows From Investing Activities
PPE Investments	-25	-50	-20	-20	-80
Sale Of Investment	265	N/A	N/A	N/A	N/A
Purchase Sale Intangibles	-59	N/A	N/A	N/A	N/A
Other Investing Activity	-76	-160	13	-110	0
Investing Cash Flow	$163	$-210	$-7	$-130	$-80

Cash Flows From Financing Activities
Debt Repayment	-140	N/A	N/A	N/A	N/A
Other Financing Activity	-21	30	-20	-50	-30
Financing Cash Flow	$-161	$30	$-20	$-50	$-30

Beginning Cash Position	210	20	30	90	8
End Cash Position	277	210	20	30	90
Net Cash Flow	$67	$180	$-7	$-60	$80

Free Cash Flow
Operating Cash Flow	65	370	20	120	200
Capital Expenditure	-25	N/A	N/A	N/A	N/A
Free Cash Flow	40	370	20	120	200